NCET2 Launches its webinar schedule for the 2nd Quarter of 2014. Bringing together expert speakers and resource persons, the offerings for this quarter include a free webinar series with the US Small Business Administration on the current SBIR/STTR programs and the Application Online Workshop series in Applying to the NSF and NIH SBIR Programs for First-time Applicants. For those interested in developing their research into a product, join us on April 15 with Dr. Art Gooray as he facilitates the 5-session certificate course on "Product Development and the Innovation Process for Researchers."
Interest: # 8. Corporate venture capital picks up the slack
As traditional venture firms pull away from funding life sciences start-ups, corporate capital will pick up the slack in 2014. With many corporations cash rich – but R&D poor – new venture funds may be a solution for stagnating innovation.
Interest: Based on healthcare industry predictions made last year by leaders and analysts, this year should have brought a re-evaluation of meaningful use (yep), a quantified self movement that would move mainstream (ehhh), more M&A activity in the industry (definitely) and the emergence of interoperability as a competitive benchmark for providers (not quite yet?).
Join the SBA for the next webinar installment with Ms. Susan Nichols, Program Manager of the DARPA SBIR/STTR programs, which reflect the Agency's compliance with the small business program goals set by DoD's Office of Small Business Programs. The webinar will take place today Thursday November 21st at 3:00PM EDT
If you are the owner, leader or manager of an entrepreneurial organization who wants to see their business involved in the DARPA space, then this is the webinar for you.
Interest: The health benefits of the National
Institutes of Health (NIH) research
support are clear: investment in
NIH directly leads to better medicines,
equipment and delivery systems
to prevent and cure disease. Additionally
NIH plays a notable role as
an economic engine, helping maintain
Interest: A few months ago a venture capital company I consult for asked me to visit the offices of Baker–Calling, a Santa Monica–based start-up trying to build a better microphone for use in smartphones and tablets. Baker–Calling’s founder, Robert Littrell, has been working on this problem for eight years—first while earning an engineering PhD at the University of Michigan, and now as the CEO of his five-person company.
Interest: When you think about what startups and their venture capitalists should focus on, does corporate governance quickly come to mind? Probably not. But it should. As with public company boards of directors, boards of venture backed companies should emphasize strategy execution and risk oversight. Startups, though, face special challenges. - See more at: http://www.dypadvisors.com/2010/10/12/three-corporate-governance-issues-venture-capital-backed-startups/#sthash.1jYkrokY.dpuf
Interest: With Bradenton emerging as an up-and-coming hip place, though, opportunities to engage and recruit young entrepreneurs and technology wizards are in play. This week's news that the Friendly City is primed to become home to a business incubator is another indication of Bradenton's bright future.
Interest: Mary Phillips has been named director for the Office of Research Development, a new unit within the Research Office, effective Dec. 1.
Phillips is associate director for the Office for Commercialization and Corporate Development, where she oversees the management of intellectual property and licensing of OSU inventions. Phillips will work with faculty and academic units to identify and pursue major funding opportunities, including federal, nonprofit and corporate sources.
Interest: Researchers, led by University of Washington (UW) physicist Jens Gundlach, have developed a nanopore sequencing technology that is capable of reading the sequence of a single DNA molecule. In this system, the DNA is pulled through a nanopore while an ion current through the pore electronically reads the DNA's sequence. The nanopore is an engineered protein developed specifically for DNA sequencing by Gundlach's team in collaboration with Michael Niederweis, a microbiologist at the University of
Interest: In fiscal year 2011, Penn made $14 million from its research.
Research at the University has seen a rise in commercialization, meaning that it is monetized through business ventures like startup companies and licensing agreements with corporations. In 2012, the university held 186 commercialization agreements, compared to only 46 agreements in 2008.
Interest: OurCrowd, Israel's leading equity crowdfunding platform for accredited investors, announced today that it has closed a strategic co-investment partnership with GE Ventures, the corporate venture capital unit of GE.
Under the agreement, GE Ventures will have the right to co-invest with OurCrowd in select early stage companies in the areas of energy, healthcare, software and advanced manufacturing.
Interest: Trochu and an executive from Dallas-based 7-Eleven Inc.’s corporate venture arm will participate in a panel discussion on corporate venture capital at Thursday’s meeting of Southern Methodist University’s Southwest Venture Forum. They will talk about the history of their company’s venture investments, how they are structured, their objectives and results.
Interest: You are Invited - NCI SBIR Contracts Funding Webinar
Wednesday, October 30, 2013, 3:00 p.m. – 4:30 p.m. EDT
Register Today: http://bit.ly/NCIsbir1030
Learn about current high priority funding areas of the National Cancer Institute Small Business Innovation Research (NCI SBIR) Program in the SBIR Contract Solicitation PHS 2014-1 due November 13. Contract funding opportunities are only available once a year, so don't miss your chance.
Interest: High quality global journalism requires investment. Please share this article with others using the link below, do not cut & paste the article. See our Ts&Cs and Copyright Policy for more detail. Email
to buy additional rights. http://www.ft.com/cms/s/0/ddf133bc-2c25-11e3-acf4-00144feab7de.html#ixzz2j5YUExMu
Keith Gillard, general partner at Pangaea Ventures, based in Vancouver, thinks his company’s expertise has enabled it to benefit from the funding crisis in the clean
Interest: University of Rochester officials have renamed their technology transfer office URVentures and announced a new plan to aggressively pursue the commercialization of technologies developed by its researchers and students.
Interest: According to a recent study by PitchBook, a Seattle-based research firm, UC Berkeley is one of the top universities for producing venture-capital-backed entrepreneurs. The report shows that from 2010 to the third quarter of 2013, UC Berkeley ranked second worldwide with 160 graduates receiving venture capital funds — 30 less than Stanford University, which placed first.
Interest: In a crowded hotel conference room in downtown Brooklyn, N.Y., in October, Jerry Engel told dozens of earnest young scientists and engineers to cut the “scientific crap” and instead identify would-be customers who might care about their products. Frank Rimalovski piled on, urging attendees presenting research that they wanted to turn into businesses—from bone grafts to facial-recognition software—“to focus on the problem, not the solution.”